Subclinical hypothyroidism and cardiovascular risk: Recommendations for treatment

Irene A. Weiss, Noah Bloomgarden, William H. Frishman

Research output: Contribution to journalReview article

11 Scopus citations

Abstract

The definition of subclinical hypothyroidism (SCH) is solely biochemical: a serum free T4 level within the reference range in the presence of an elevated serum thyroid-stimulating hormone (TSH) level. While overt hypothyroidism is associated with an increased cardiovascular disease risk, SCH, the mildest form of hypothyroidism, may also be associated with an increased cardiovascular disease risk, but to a lesser degree. Recent evidence points to a significant trend toward an increase in cardiovascular risk at higher TSH levels, with TSH levels ≥10 mIU/L associated with increased cardiovascular morbidity and mortality. It is generally recommended to treat with thyroid hormone those individuals with SCH and TSH values ≥10 mIU/L. Treatment of patients with SCH and TSH values <10 is controversial but may be considered in selected patients.

Original languageEnglish (US)
Pages (from-to)291-299
Number of pages9
JournalCardiology in review
Volume19
Issue number6
DOIs
StatePublished - Nov 1 2011

Keywords

  • cardiovascular complications
  • subclinical hypothyroidism
  • thyroid replacement
  • thyroid stimulating hormone

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Subclinical hypothyroidism and cardiovascular risk: Recommendations for treatment'. Together they form a unique fingerprint.

  • Cite this